Urinary incontinence is increasingly seen in the physician's office, because of both its high prevalence (20% to 30% of middle-aged and 30% to 50% of elderly women 1 ) and the growing expectations for relief by women affected by it. More and more the psychosocial impact of urinary incontinence becomes an important aspect, and several disease-specific tools have been designed to measure quality of life. 2-4 A number of careful steps must be followed in questionnaire development (Table I) . 5 The Incontinence Impact Questionnaire (IIQ) was designed by Shumaker et al 2 to assess the impact of urinary incontinence on activities and emotions in women. Thirty self-administered questions cover four domains: physical activity, social relationships, travel, and emotional health. Each question has a 4-point response scale; patients are asked to rate the extent to which their urinary incontinence affects their daily functioning (0, not at all; 1, slightly; 2, moderately; 3, greatly) (see Appendix 1). No time anchor is included in their formulation of the questions. The Urogenital Distress Inventory (UDI), which is meant to complement the IIQ, was developed at the same time by the same group to assess the degree to which symptoms associated with incontinence are troubling. It consists of 19 questions covering 3 domains: symptoms related to stress urinary incontinence, detrusor overactivity, and bladder outlet obstruction. The response scale is the same as the IIQ (Appendix 2).
Urinary incontinence is increasingly seen in the physician's office, because of both its high prevalence (20% to 30% of middle-aged and 30% to 50% of elderly women 1 ) and the growing expectations for relief by women affected by it. More and more the psychosocial impact of urinary incontinence becomes an important aspect, and several disease-specific tools have been designed to measure quality of life. [2] [3] [4] A number of careful steps must be followed in questionnaire development (Table I) . 5 The Incontinence Impact Questionnaire (IIQ) was designed by Shumaker et al 2 to assess the impact of urinary incontinence on activities and emotions in women. Thirty self-administered questions cover four domains: physical activity, social relationships, travel, and emotional health. Each question has a 4-point response scale; patients are asked to rate the extent to which their urinary incontinence affects their daily functioning (0, not at all; 1, slightly; 2, moderately; 3, greatly) (see Appendix 1) . No time anchor is included in their formulation of the questions. The Urogenital Distress Inventory (UDI), which is meant to complement the IIQ, was developed at the same time by the same group to assess the degree to which symptoms associated with incontinence are troubling. It consists of 19 questions covering 3 domains: symptoms related to stress urinary incontinence, detrusor overactivity, and bladder outlet obstruction. The response scale is the same as the IIQ (Appendix 2).
Shumaker et al 2 assessed the validity, reproducibility, and sensitivity to change of the full-length IIQ and UDI in a population of community-dwelling women recruited in an uncontrolled clinical study. All patients had to fulfill urodynamic criteria of genuine stress incontinence or detrusor instability. They reported a low but significant correlation with incontinence severity on the 1-hour pad test (r = 0.27). The authors concluded from this and other psychometric tests that the questionnaires were reliable and valid.
Short forms of the IIQ and UDI were developed with the original data 2 on the full-length questionnaire. Regression analyses suggested that a 7-to 8-item questionnaire would accurately predict the IIQ long from total score, and a 6-item form would predict the UDI long form. Items constituting the short forms (the IIQ-7 and the UDI-6 6 ) are shown in bold in Appendixes 1 and 2.
The short forms were validated through correlations with long-form scores and with clinical data. Abrams et al 7 report a significant correlation with the 1h pad test. Independent investigators have carried out additional validation studies, also in women selected on the basis of formal urodynamic testing. 8, 9 They have found that variables pertaining to frequency and volume of loss could predict the score of the IIQ-7 and UDI-6. 6 In addition, positive responses to subscale questions (obstruction, stress incontinence or overactivity) are correlated with the corresponding urodynamic (UDS) diagnosis. 9 The weight of accumulated evidence suggests that the IIQ and UDI, both short and long forms, are valid for use with women who have a priori urodynamic diagnosis of urinary incontinence. However, neither the short forms nor the long forms have ever been validated in women without such diagnosis. The validity of a measurement is dependent on the population being measured. 5 Therefore, if a scale is to be used on a different population, psychometric properties must be reestablished. The purpose of this study is to assess the reliability and validity of the IIQ and UDI (long and short) in community-dwelling women with no a priori UDS diagnosis. In addition, we wanted to determine whether a simpler method of scoring the long forms (simple addition) would yield similar results.
Methods
Data from a prospective before/after clinical trial on the efficacy of an external urethral device were used in the validation study. 10 Women were enrolled either through referral from an academic urogynecology practice or from the community to participate in the 4-week trial. Advertisements in local newspapers and radio stations were used to recruit participants. Patients underwent a standardized history (including grading on a scale of 4 [none, mild, moderate, and severe] different urinary symptoms) and a physical examination at the time of recruitment. Inclusion and exclusion criteria are reported elsewhere. 10 All patients completed the long forms of the IIQ and UDI and underwent a standardized 1-hour pad test at baseline. Subjects then wore the device for 1 month. At the end of the month, they were asked to repeat the tests while wearing the device. Local institutional review board approval was obtained at the time of the original data collection.
Scores on the long forms of the IIQ and UDI were calculated in 2 fashions: with the method recommended by the scale authors, in which a score was generated for each subscale and all subscales were weighted equally, and in a simple additive fashion because this is more convenient. Correlation between the 2 methods was obtained by use of the Pearson's correlation coefficient. The assessment of validity and internal consistency were done for each method of scoring.
Internal consistency of the long forms was assessed with Cronbach's alpha. Validity was assessed through correlation with the 1h pad test (Spearman's rho) and receiveroperator curve (ROC) analyses against the pad test, which was dichotomized as positive (>2 g) or negative (2 g). Criterion validation was also done by correlating the scales score with the symptoms patients reported at baseline. Sensitivity to change was assessed by use of the Wilcoxon signed rank test. Confirmation that a change was present was assessed by use of the Wilcoxon signed rank test for comparing the pad test results (with versus without the device).
Scores for the short forms were extracted from the long form questionnaires, and an average of the items responded to were calculated, according to scale developers' instruction. Reliability of the short form was studied by use of inter-item correlation, item-total statistics, and coefficient alpha. For the inter-item correlation, items should correlate with each other, but a very high interitem correlation is indicative of redundancy. In the latter two techniques, the analyses evaluate the correlation of each individual item with the overall score of the test calculated without that item. This represents a method for checking the homogeneity of the scale. 5 Two methods were used: simple correlation and item-total statistic with Cronbach's alpha. The first method consists of calculating the correlation of the individual item, with the scale total omitting that item, with Pearson's correlation. In the second method, an alpha for the total score is calculated with individual items deleted one at the time. If the alpha increases significantly when a specific item is left out, then its exclusion would increase the homogeneity of the test. To assess the appropriateness of choice of items on the short form, we studied item-total correlation for the long form.
Statistical significance was set at a P value of .05. All analyses were performed with SPSS for Windows 9.0 (SPSS Inc, Chicago, Ill).
Results
One hundred fifty-five women were enrolled in the study. Five women dropped out after enrollment; thus baseline data are available for 150 women. Validity and reliability studies were performed on this group. Fifty-two women dropped out before follow-up, leaving 98 patients for whom end-of-study data are available. Evaluation of sensitivity to change was performed on those 98 patients. Reasons for dropping out, as well as the comparison between included/excluded subjects, are given in the original report. 10 They did not differ from women who completed the trial with regard to age, body mass index (BMI), vaginal parity, or urinary symptoms expressed at onset. Demographic characteristics of the 150 women with baseline data are shown in Table II .
When compared, the two methods of calculating the long form scores were highly correlated (0.91 for the UDI and 0.99 for the IIQ). In addition, the method of scoring had little impact on validity and reliability evaluations; there was little difference in results for the two scoring methods. Therefore for the sake of simplicity and clarity, only the "simple addition" score will be used in the analyses presented herein.
Long forms. Results for the reliability study (Cronbach's alpha), convergent validity and sensitivity to change are presented in Table III . Coefficient alpha for the IIQ was high, whereas that for the UDI was good.
ROC analysis showed that scores on the questionnaire were largely unrelated to incontinence, as measured by the pad test: the area under the curve was only 0.543 and 0.513, for the IIQ and the UDI respectively (Fig 1) . An area under the curve of 0.50 indicates a 50% probability of correct classification. Thus this test performed little better than chance alone in classifying a patient as incontinent (as defined by a positive pad test result). No correlation between the pad test result and the questionnaires was found as shown in Table III . When correlations were performed against the clinical symptoms expressed by the patients, only the UDI showed consistent, albeit weak, correlations (Table IV) .
The null hypothesis that the tests without and with the device were the same was tested. The pad test result was significantly different (Z= -5.539, P < .01) with and without the device, indicating that it was sensitive to change. The change in questionnaire score was also significantly different while the patient was wearing the device, indicating that it too was sensitive to change (Table III) .
Short forms
Reliability studies INCONTINENCE IMPACT QUESTIONNAIRE. Items had low to moderate correlation with each other (range 0.24 to 0.66). Item total correlation revealed moderate to good correlation between individual items and the short form score (range 0.47 to 0.66). The Cronbach's alpha for internal consistency is shown in Table III ; it was moderately high. Inter-item correlations on the long form revealed that the 7 items that correlated best with the total score of the long form were questions 1, 3, 6, 8, 12, 20, and 29.
UROGENITAL DISTRESS INVENTORY Items in this scale showed moderate correlation of the items of the short form to each other (range 0.04 to 0.57). Item analysis revealed a weak and inverse correlation for item 4 (-0.09) and poor correlation between other items (range 0.23 to 0.44) and the short form score. The Cronbach's alpha for internal consistency was low at 0.53. Inter-item correlation performed on the long form revealed that the 6 items that correlated best with the total score of the long form were questions 1, 3, 4, 6, 13, and 14. However, when we attempted to validate these modified short versions against either the pad test results or the change in pad test measurement, validity was not better (data not shown).
Validity. Convergent validity results for the short forms are presented in Table III . The correlation between the short and long forms of the IIQ and UDI were both high. There was little correlation between the short forms of the IIQ and UDI and the weight of the pad test. The ROC curve analysis revealed that the questionnaires do not have any discriminant power in predicting an abnormal pad test result: AUC were quite low, at 0.58 and 0.53, respectively. Validity against clinical symptoms, as in the case of the long forms, showed significant correlation, although weak to moderate, only for the UDI-6 (Table IV) .
Sensitivity to change. The scale scores were significantly different with and without the device, indicating that they were also sensitive to change (Table III) . The change in score value was then correlated with the change in pad test by use of Spearman's correlation. No correlation between the change in the pad test score and the change in test score was found.
Role of patients' characteristics. The role of BMI, vaginal parity, and age as predictors of the questionnaire scores were sought. Nonparametric correlations (Spearman's) were used. A weak inverse correlation (r = -0.16, P < .05) was found between age and the IIQ and IIQ-7, signifying that as age increased, scores were lower. Similarly, a weak correlation was noted between the BMI and the IIQ (r = 0.17, P < .05) and the UDI-6 (r = 0.21, P < .05); scores on the questionnaires were higher for people with higher BMI. No correlation was found with vaginal parity.
Discussion
We have found that the IIQ and the UDI, either long or short, do not appear to be valid in a population in whom no prior urodynamic diagnosis has been established, when validity is assessed with the criterion of 1h pad test. The lack of validity is most likely due to differences between our population and the population in whom the questionnaires were originally evaluated. It is important that, before application in a new population, a questionnaire instrument be validated in that new setting. The quality of life questionnaires studied are frequently distributed to women before any urodynamic evaluation in both clinical and research settings. Our analysis demonstrates that, in patients recruited from the community on the basis of subjective complaints of urinary incontinence and without an established urodynamic diagnosis, these questionnaires are invalid as markers of urinary incontinence severity. A population consisting of women with an established UDS diagnosis may differ in terms of pathophysiological condition and severity of incontinence from the population of all patients with the complaint of urinary incontinence. Moreover, urodynamic studies may have false-negative results. The relative insensitivity of standard multichannel urodynamic studies in detecting detrusor instability has been highlighted in many ambulatory-monitoring studies performed on subjects with symptoms. [11] [12] [13] In addition, authors agree that symptoms are not a good predictor for the UDS diagnosis of stress incontinence 14 or mixed or urge incontinence. 15 The original trial had been designed to assess the effectiveness of an external urethral device as close as possible to what would happen in general practice. Nonetheless, our population probably differ somewhat from that of the general population because subjects participating in trials are often not representative of the general population (eg, they may be healthier and more educated).
Another explanation for our findings is that the 1-hour pad test is not a good gold standard of severity to assess impact of incontinence on quality of life. Pad tests may help to measure the severity of incontinence. However, the assumption that the more severe the incontinence, the greater the effect on the quality of live is debatable. A patient with urgency/frequency and occasional urge incontinence may have a decreased quality of life as measured by the IIQ or the UDI, but the pad test result will be negative. Similarly, a patient may have mild stress incontinence during a specific activity (eg, playing tennis), and it may be perceived as very problematic. Furthermore, two patients with the same severity of incontinence might be affected in a different manner by their condition. A better indicator of quality of life might be the frequency of micturition, perceived leakage quantity, number of incontinence episodes/24 hours, as suggested by Robinson et al 8 16 However, its use in the evaluation of incontinence is questionable because it has not proven to be very accurate in detecting the presence or the severity incontinence, unless the bladder volume is fixed at 200 to 300 mL or 50% to 75% of bladder capacity. This could explain why we did not find a relationship between the pad test and the scales.
We also found that the long-and short-form UDI correlated well with actual symptoms of which the patients complained, which is reassuring, because this questionnaire is meant to probe specifically the presence and bothersomeness of urinary symptoms. However, the IIQ did not correlate well with symptoms experienced by the patients, meaning that the impact on the life activities of the incontinence did not correlate with the importance the patient was attributing to her symptoms.
In the analyses evaluating which items should constitute a short version, we have arrived at divergent results from the scale developers for the IIQ-7. In fact, we would retain items 3, 12, and 29 instead of 5, 15, and 27. However, psychometric properties were not improved.
The original IIQ and UDI were not designed to discriminate between urge and stress incontinence, and the validation study was not performed according to UDS diagnosis. It is therefore possible that such discrimination would have helped determine for which of the two groups (urge or stress) this questionnaire might have been more valid. However, the design of our original trial did not include UDS diagnosis, preventing us from performing such an analysis.
Our sample size was small, according to that routinely used in psychometrics studies, where typically 10 subjects per item are used. The IIQ includes 30 items, and as such, a sample of 300 subjects would ideally be required. Nonetheless, our sample size was similar to that of the original scale developers (162 subjects).
Although we agree in principle that all subscales are of equal importance and therefore warrant weight adjustment as a result of the unequal number of questions in each subscales, we have not found an alteration in the validation or in the sensitivity to change when performed with either methods (ie, weighted score versus simple addition score, data not shown). We are therefore challenging the scoring method of the questionnaires. The original report recommended generating a mean score for each subscale and transforming it to attribute equal weight to all the subscales; this would prevent giving higher weight to subscales with more questions. Calculated this way, scores range from 0 to 400 for the IIQ and from 0 to 300 for the UDI. This method of scoring is cumbersome. We have concluded that simple addition shows similar results. Authorities in the field of health measurement scales suggest that in scales with fewer than 20 or 40 items, weighting may have some effect, supporting the position of the scale developers. However, if the items are relatively homogeneous (as in these scales), the effect of weighting may be minimal.
Finally, a note of caution is appropriate regarding the development of short forms of scales. Ideally, patients would independently and at different times complete the long and the short versions of a questionnaire. This would allow a more robust validation of such scales. However, neither in this study nor in the original development was this done, perhaps accounting for the limited correlation found.
Further studies are necessary to assess the role of the IIQ and UDI in the clinical setting. These tools remain valid in the research setting where patients are enrolled on the basis of UDS criteria and on whom an intervention is being evaluated. The ideal interval between preintervention and postintervention application of a questionnaire was not evaluated in our setting, and we therefore cannot suggest an answer. Nonetheless, their validity is not supported for diagnosis, or for the assessment of intervention, in the clinical setting in the absence of urodynamic evaluation. This study highlights the importance of using a survey only in the population for whom it was validated.
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